+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Housing Finance Market By Application, By Providers: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • PDF Icon

    Report

  • 358 Pages
  • August 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671278
UP TO OFF until Jan 30th 2025
Housing finance is a type of loan which is used to purchase or maintain a home, land, or other types of housing. Furthermore, with growing housing’s business across the globe the need for housing finances is rising which in turn drives the growth of the market. In addition, housing finance is one of the most affordable means of borrowing money compared to any other type of loan. In addition to this, housing finance are mainly offered by banks, independent lenders, insurance companies, pension funds, private investors, and other capital sources.

Growing need to streamline housing lending service and increase in need for money among businesses and individuals to purchase housing boost the growth of the housing finance market. In addition, flexible period to repay the finance amount positively impacts the growth of the market. However, factors such as enforcement of strong rules by banks and financial institutions for providing finance is expected to hamper the market growth. On the contrary, rising prices of housing properties in developing countries and penetration of metropolitan cities across the globe are expected to offer remunerative opportunities for the expansion of the market during the forecast period.

The housing finance market is segmented on the basis of application, provider, and region. By application, it is segmented into home purchase, refinance, home improvement, and other purpose. The home purchase segment is further sub segmented into conventional and non-conventional. The conventional sub segment is further divided into low & moderate income (LMI) borrowers, and high income borrowers. By provider, it is bifurcated into banks, housing finance companies, real estate agents, and others. By region, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.

The report analyzes the profiles of key players operating in the housing finance market such as Bank of America Corporation, Charles Schwab & Co., Citigroup, Inc., CREDIT SUISSE GROUP AG, Dewan Housing Finance Corporation Ltd., Goldman Sachs, HSBC Group, JPMorgan Chase & Co., LIC Housing Finance Ltd., Lloyd's Banking Group, Morgan Stanley, Royal Bank of Canada, Royal Bank of Scotland plc, UBS, Wells Fargo, Divvy Homes, Inc., and Pronto Housing. These players have adopted various strategies to increase their market penetration and strengthen their position in the housing finance industry.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the housing finance market analysis from 2021 to 2031 to identify the prevailing housing finance market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the housing finance market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global housing finance market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Home Purchase
  • Refinance
  • Home Improvement
  • Other Purpose

By Providers

  • Banks
  • Housing Finance Companies
  • Real Estate Agents
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Singapore
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Bank of America Corporation
  • Charles Schwab & Co.
  • Citigroup, Inc.
  • CREDIT SUISSE
  • Dewan Housing Finance Corporation Limited
  • Goldman Sachs
  • HSBC Group
  • JPMorgan Chase & Co.
  • LIC Housing Finance Limited
  • Lloyd's Banking Group
  • Morgan Stanley
  • Royal Bank of Canada
  • The Royal Bank of Scotland Plc
  • UBS
  • Wells Fargo

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: HOUSING FINANCE MARKET, BY APPLICATION
4.1 Overview
4.1.1 Market size and forecast
4.2 Home Purchase
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Refinance
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Home Improvement
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Other Purpose
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
CHAPTER 5: HOUSING FINANCE MARKET, BY PROVIDERS
5.1 Overview
5.1.1 Market size and forecast
5.2 Banks
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Housing Finance Companies
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Real Estate Agents
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: HOUSING FINANCE MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Application
6.2.3 North America Market size and forecast, by Providers
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Application
6.2.4.1.2 Market size and forecast, by Providers
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Application
6.2.4.2.2 Market size and forecast, by Providers
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Application
6.3.3 Europe Market size and forecast, by Providers
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Application
6.3.4.1.2 Market size and forecast, by Providers
6.3.4.2 United Kingdom
6.3.4.2.1 Market size and forecast, by Application
6.3.4.2.2 Market size and forecast, by Providers
6.3.4.3 France
6.3.4.3.1 Market size and forecast, by Application
6.3.4.3.2 Market size and forecast, by Providers
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Application
6.3.4.4.2 Market size and forecast, by Providers
6.3.4.5 Spain
6.3.4.5.1 Market size and forecast, by Application
6.3.4.5.2 Market size and forecast, by Providers
6.3.4.6 Netherlands
6.3.4.6.1 Market size and forecast, by Application
6.3.4.6.2 Market size and forecast, by Providers
6.3.4.7 Rest of Europe
6.3.4.7.1 Market size and forecast, by Application
6.3.4.7.2 Market size and forecast, by Providers
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Application
6.4.3 Asia-Pacific Market size and forecast, by Providers
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Application
6.4.4.1.2 Market size and forecast, by Providers
6.4.4.2 India
6.4.4.2.1 Market size and forecast, by Application
6.4.4.2.2 Market size and forecast, by Providers
6.4.4.3 Japan
6.4.4.3.1 Market size and forecast, by Application
6.4.4.3.2 Market size and forecast, by Providers
6.4.4.4 Australia
6.4.4.4.1 Market size and forecast, by Application
6.4.4.4.2 Market size and forecast, by Providers
6.4.4.5 Singapore
6.4.4.5.1 Market size and forecast, by Application
6.4.4.5.2 Market size and forecast, by Providers
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Market size and forecast, by Application
6.4.4.6.2 Market size and forecast, by Providers
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Application
6.5.3 LAMEA Market size and forecast, by Providers
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Application
6.5.4.1.2 Market size and forecast, by Providers
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Application
6.5.4.2.2 Market size and forecast, by Providers
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Application
6.5.4.3.2 Market size and forecast, by Providers
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Bank of America Corporation
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Charles Schwab & Co.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Citigroup, Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 CREDIT SUISSE
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Dewan Housing Finance Corporation Limited
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Goldman Sachs
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 HSBC Group
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 JPMorgan Chase & Co.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 LIC Housing Finance Limited
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Lloyd's Banking Group
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
8.11 Morgan Stanley
8.11.1 Company overview
8.11.2 Company snapshot
8.11.3 Operating business segments
8.11.4 Product portfolio
8.11.5 Business performance
8.11.6 Key strategic moves and developments
8.12 Royal Bank of Canada
8.12.1 Company overview
8.12.2 Company snapshot
8.12.3 Operating business segments
8.12.4 Product portfolio
8.12.5 Business performance
8.12.6 Key strategic moves and developments
8.13 The Royal Bank of Scotland Plc
8.13.1 Company overview
8.13.2 Company snapshot
8.13.3 Operating business segments
8.13.4 Product portfolio
8.13.5 Business performance
8.13.6 Key strategic moves and developments
8.14 UBS
8.14.1 Company overview
8.14.2 Company snapshot
8.14.3 Operating business segments
8.14.4 Product portfolio
8.14.5 Business performance
8.14.6 Key strategic moves and developments
8.15 Wells Fargo
8.15.1 Company overview
8.15.2 Company snapshot
8.15.3 Operating business segments
8.15.4 Product portfolio
8.15.5 Business performance
8.15.6 Key strategic moves and developments
List of Tables
Table 1. Global Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 2. Mrna Vaccines and Rnai Therapeutics Market Size, for Hereditary Transthyretin-Mediated Amyloidosis Genetic, by Region, 2021-2031 ($Million)
Table 3. Mrna Vaccines and Rnai Therapeutics Market for Hereditary Transthyretin-Mediated Amyloidosis Genetic by Country, 2021-2031 ($Million)
Table 4. Mrna Vaccines and Rnai Therapeutics Market Size, for Acute Hepatic Porphyria, by Region, 2021-2031 ($Million)
Table 5. Mrna Vaccines and Rnai Therapeutics Market for Acute Hepatic Porphyria by Country, 2021-2031 ($Million)
Table 6. Mrna Vaccines and Rnai Therapeutics Market Size, for Primary Hyperoxaluria Type 1, by Region, 2021-2031 ($Million)
Table 7. Mrna Vaccines and Rnai Therapeutics Market for Primary Hyperoxaluria Type 1 By Country, 2021-2031 ($Million)
Table 8. Mrna Vaccines and Rnai Therapeutics Market Size, for Atherosclerotic Cardiovascular Disease, by Region, 2021-2031 ($Million)
Table 9. Mrna Vaccines and Rnai Therapeutics Market for Atherosclerotic Cardiovascular Disease by Country, 2021-2031 ($Million)
Table 10. Global Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 11. Mrna Vaccines and Rnai Therapeutics Market Size, for Iv Infusion, by Region, 2021-2031 ($Million)
Table 12. Mrna Vaccines and Rnai Therapeutics Market for Iv Infusion by Country, 2021-2031 ($Million)
Table 13. Mrna Vaccines and Rnai Therapeutics Market Size, for Subcutaneous, by Region, 2021-2031 ($Million)
Table 14. Mrna Vaccines and Rnai Therapeutics Market for Subcutaneous by Country, 2021-2031 ($Million)
Table 15. Global Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 16. Mrna Vaccines and Rnai Therapeutics Market Size, for Research Institutes, by Region, 2021-2031 ($Million)
Table 17. Mrna Vaccines and Rnai Therapeutics Market for Research Institutes by Country, 2021-2031 ($Million)
Table 18. Mrna Vaccines and Rnai Therapeutics Market Size, for Hospitals and Clinics, by Region, 2021-2031 ($Million)
Table 19. Mrna Vaccines and Rnai Therapeutics Market for Hospitals and Clinics by Country, 2021-2031 ($Million)
Table 20. Mrna Vaccines and Rnai Therapeutics Market, by Region, 2021-2031 ($Million)
Table 21. North America Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 22. North America Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 23. North America Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 24. North America Mrna Vaccines and Rnai Therapeutics Market, by Country, 2021-2031 ($Million)
Table 25. U.S. Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 26. U.S. Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 27. U.S. Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 28. Canada Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 29. Canada Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 30. Canada Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 31. Mexico Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 32. Mexico Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 33. Mexico Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 34. Europe Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 35. Europe Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 36. Europe Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 37. Europe Mrna Vaccines and Rnai Therapeutics Market, by Country, 2021-2031 ($Million)
Table 38. Germany Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 39. Germany Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 40. Germany Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 41. France Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 42. France Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 43. France Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 44. U.K. Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 45. U.K. Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 46. U.K. Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 47. Italy Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 48. Italy Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 49. Italy Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 50. Spain Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 51. Spain Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 52. Spain Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 53. Rest of Europe Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 54. Rest of Europe Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 55. Rest of Europe Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 56. Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 57. Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 58. Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 59. Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by Country, 2021-2031 ($Million)
Table 60. China Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 61. China Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 62. China Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 63. Japan Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 64. Japan Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 65. Japan Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 66. India Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 67. India Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 68. India Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 69. Australia Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 70. Australia Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 71. Australia Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 72. South Korea Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 73. South Korea Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 74. South Korea Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 75. Rest of Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 76. Rest of Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 77. Rest of Asia-Pacific Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 78. LAMEA Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 79. LAMEA Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 80. LAMEA Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 81. LAMEA Mrna Vaccines and Rnai Therapeutics Market, by Country, 2021-2031 ($Million)
Table 82. Brazil Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 83. Brazil Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 84. Brazil Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 85. Saudi Arabia Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 86. Saudi Arabia Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 87. Saudi Arabia Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 88. South Africa Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 89. South Africa Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 90. South Africa Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 91. Rest of LAMEA Mrna Vaccines and Rnai Therapeutics Market, by Disease Type, 2021-2031 ($Million)
Table 92. Rest of LAMEA Mrna Vaccines and Rnai Therapeutics Market, by Route of Administration, 2021-2031 ($Million)
Table 93. Rest of LAMEA Mrna Vaccines and Rnai Therapeutics Market, by End-user, 2021-2031 ($Million)
Table 94. Alnylam Pharmaceuticals: Company Snapshot
Table 95. Alnylam Pharmaceuticals: Operating Segments
Table 96. Alnylam Pharmaceuticals: Product Portfolio
Table 97. Alnylam Pharmaceuticals: Net Sales
Table 98. Alnylam Pharmaceuticals: Key Stratergies
Table 99. Biontech Ag: Company Snapshot
Table 100. Biontech Ag: Operating Segments
Table 101. Biontech Ag: Product Portfolio
Table 102. Biontech Ag: Net Sales
Table 103. Biontech Ag: Key Stratergies
Table 104. Curevac Ag: Company Snapshot
Table 105. Curevac Ag: Operating Segments
Table 106. Curevac Ag: Product Portfolio
Table 107. Curevac Ag: Net Sales
Table 108. Curevac Ag: Key Stratergies
Table 109. Etherna Immunotherapies: Company Snapshot
Table 110. Etherna Immunotherapies: Operating Segments
Table 111. Etherna Immunotherapies: Product Portfolio
Table 112. Etherna Immunotherapies: Net Sales
Table 113. Etherna Immunotherapies: Key Stratergies
Table 114. Ethris GmbH: Company Snapshot
Table 115. Ethris GmbH: Operating Segments
Table 116. Ethris GmbH: Product Portfolio
Table 117. Ethris GmbH: Net Sales
Table 118. Ethris GmbH: Key Stratergies
Table 119. In-Cell-Art: Company Snapshot
Table 120. In-Cell-Art: Operating Segments
Table 121. In-Cell-Art: Product Portfolio
Table 122. In-Cell-Art: Net Sales
Table 123. In-Cell-Art: Key Stratergies
Table 124. Moderna Therapeutics: Company Snapshot
Table 125. Moderna Therapeutics: Operating Segments
Table 126. Moderna Therapeutics: Product Portfolio
Table 127. Moderna Therapeutics: Net Sales
Table 128. Moderna Therapeutics: Key Stratergies
Table 129. Sangamo Therapeutics, Inc.: Company Snapshot
Table 130. Sangamo Therapeutics, Inc.: Operating Segments
Table 131. Sangamo Therapeutics, Inc.: Product Portfolio
Table 132. Sangamo Therapeutics, Inc.: Net Sales
Table 133. Sangamo Therapeutics, Inc.: Key Stratergies
Table 134. Sanofi Ag: Company Snapshot
Table 135. Sanofi Ag: Operating Segments
Table 136. Sanofi Ag: Product Portfolio
Table 137. Sanofi Ag: Net Sales
Table 138. Sanofi Ag: Key Stratergies
Table 139. Scm Life Sciences (Argos Therapeutics, Inc. ): Company Snapshot
Table 140. Scm Life Sciences (Argos Therapeutics, Inc. ): Operating Segments
Table 141. Scm Life Sciences (Argos Therapeutics, Inc. ): Product Portfolio
Table 142. Scm Life Sciences (Argos Therapeutics, Inc. ): Net Sales
Table 143. Scm Life Sciences (Argos Therapeutics, Inc. ): Key Stratergies
Table 144. Sarepta Therapeutics: Company Snapshot
Table 145. Sarepta Therapeutics: Operating Segments
Table 146. Sarepta Therapeutics: Product Portfolio
Table 147. Sarepta Therapeutics: Net Sales
Table 148. Sarepta Therapeutics: Key Stratergies
Table 149. Arcturus Therapeutics: Company Snapshot
Table 150. Arcturus Therapeutics: Operating Segments
Table 151. Arcturus Therapeutics: Product Portfolio
Table 152. Arcturus Therapeutics: Net Sales
Table 153. Arcturus Therapeutics: Key Stratergies
Table 154. Ionis Pharmaceuticals, Inc: Company Snapshot
Table 155. Ionis Pharmaceuticals, Inc: Operating Segments
Table 156. Ionis Pharmaceuticals, Inc: Product Portfolio
Table 157. Ionis Pharmaceuticals, Inc: Net Sales
Table 158. Ionis Pharmaceuticals, Inc: Key Stratergies
Table 159. Nutcracker: Company Snapshot
Table 160. Nutcracker: Operating Segments
Table 161. Nutcracker: Product Portfolio
Table 162. Nutcracker: Net Sales
Table 163. Nutcracker: Key Stratergies
Table 164. Tiba Biotech: Company Snapshot
Table 165. Tiba Biotech: Operating Segments
Table 166. Tiba Biotech: Product Portfolio
Table 167. Tiba Biotech: Net Sales
Table 168. Tiba Biotech: Key Stratergies
List of Figures
Figure 1. Housing Finance Market Segmentation
Figure 2. Housing Finance Market,2021-2031
Figure 3. Housing Finance Market,2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Housing Finance Market:Drivers, Restraints and Opportunities
Figure 12. Housing Finance Market,By Application,2021(%)
Figure 13. Comparative Share Analysis of Home Purchase Housing Finance Market,2021-2031(%)
Figure 14. Comparative Share Analysis of Refinance Housing Finance Market,2021-2031(%)
Figure 15. Comparative Share Analysis of Home Improvement Housing Finance Market,2021-2031(%)
Figure 16. Comparative Share Analysis of Other Purpose Housing Finance Market,2021-2031(%)
Figure 17. Housing Finance Market,By Providers,2021(%)
Figure 18. Comparative Share Analysis of Banks Housing Finance Market,2021-2031(%)
Figure 19. Comparative Share Analysis of Housing Finance Companies Housing Finance Market,2021-2031(%)
Figure 20. Comparative Share Analysis of Real Estate Agents Housing Finance Market,2021-2031(%)
Figure 21. Comparative Share Analysis of Others Housing Finance Market,2021-2031(%)
Figure 22. Housing Finance Market by Region,2021
Figure 23. U.S. Housing Finance Market,2021-2031($Billion)
Figure 24. Canada Housing Finance Market,2021-2031($Billion)
Figure 25. Germany Housing Finance Market,2021-2031($Billion)
Figure 26. United Kingdom Housing Finance Market,2021-2031($Billion)
Figure 27. France Housing Finance Market,2021-2031($Billion)
Figure 28. Italy Housing Finance Market,2021-2031($Billion)
Figure 29. Spain Housing Finance Market,2021-2031($Billion)
Figure 30. Netherlands Housing Finance Market,2021-2031($Billion)
Figure 31. Rest of Europe Housing Finance Market,2021-2031($Billion)
Figure 32. China Housing Finance Market,2021-2031($Billion)
Figure 33. India Housing Finance Market,2021-2031($Billion)
Figure 34. Japan Housing Finance Market,2021-2031($Billion)
Figure 35. Australia Housing Finance Market,2021-2031($Billion)
Figure 36. Singapore Housing Finance Market,2021-2031($Billion)
Figure 37. Rest of Asia-Pacific Housing Finance Market,2021-2031($Billion)
Figure 38. Latin America Housing Finance Market,2021-2031($Billion)
Figure 39. Middle East Housing Finance Market,2021-2031($Billion)
Figure 40. Africa Housing Finance Market,2021-2031($Billion)
Figure 41. Top Winning Strategies, by Year
Figure 42. Top Winning Strategies, by Development
Figure 43. Top Winning Strategies, by Company
Figure 44. Product Mapping of Top 10 Players
Figure 45. Competitive Dashboard
Figure 46. Competitive Heatmap of Top 10 Key Players
Figure 47. Bank of America Corporation.: Net Sales ,($Billion)
Figure 48. Charles Schwab & Co..: Net Sales ,($Billion)
Figure 49. Citigroup, Inc..: Net Sales ,($Billion)
Figure 50. Credit Suisse.: Net Sales ,($Billion)
Figure 51. Dewan Housing Finance Corporation Limited.: Net Sales ,($Billion)
Figure 52. Goldman Sachs.: Net Sales ,($Billion)
Figure 53. HSBC Group.: Net Sales ,($Billion)
Figure 54. Jpmorgan Chase & Co..: Net Sales ,($Billion)
Figure 55. Lic Housing Finance Limited.: Net Sales ,($Billion)
Figure 56. Lloyd's Banking Group.: Net Sales ,($Billion)
Figure 57. Morgan Stanley.: Net Sales ,($Billion)
Figure 58. Royal Bank of Canada.: Net Sales ,($Billion)
Figure 59. The Royal Bank of Scotland PLC.: Net Sales ,($Billion)
Figure 60. Ubs.: Net Sales ,($Billion)
Figure 61. Wells Fargo.: Net Sales ,($Billion)

Executive Summary

According to the report, titled, “Housing Finance Market," the housing finance market size was valued at $4,520.67 billion in 2021, and is estimated to reach $33,298.79 billion by 2031, growing at a CAGR of 22.3% from 2022 to 2031.

Furthermore, major companies are launching their schemes to offer housing finance to customers. For instance, Citi bank has established affordable housing preservation program. The program will acquire multifamily housing primarily for the benefit of low to moderate income individuals and communities including workforce, regulated and mixed-income housing with a commitment to community development and engaging diverse professionals throughout the acquisition and ownership infrastructures.

On the basis of provider, the banks segment is the highest growing segment. This is attributed to the growth in focus on digitalization of financial processes has transformed traditional banking systems, owing to which various banks are providing housing finance to significantly support rise in consumer needs. In addition, growth in digitization across the banking sector has filled existing gaps in financial services and increased efficiency among the banking sector to provide better customer experience, which drives the housing finance market growth.

Based on region, North America attained the highest growth in 2021. This is attributed to the increase in adoption of digital lending platforms among banking and financial services for improving financing services is considered as an important factor for growth of the housing finance market trends in this segment. In addition, rise in adoption of advance technologies such as e-signatures, artificial intelligence (AI), machine learning, and advanced analytics among house financing service companies for identifying fraudulent activities in lending service propels growth of the market in North America.

The COVID-19 pandemic had a negative impact on the market attributing to the fact that consumers that planned on purchasing new homes had to postpone their plans due to closure of business and fall in their income. Therefore, the pandemic negatively impacted the housing finance market growth.

Key Findings of the Study

  • By application, the home purchase segment led the housing finance market share in terms of revenue in 2021.
  • By region, North America generated the highest revenue in 2021.
  • The key players profiled in the housing finance market analysis are Bank of America Corporation, Charles Schwab & Co., Citigroup, Inc., CREDIT SUISSE GROUP AG, Dewan Housing Finance Corporation Ltd., Goldman Sachs, HSBC Group, JPMorgan Chase & Co., LIC Housing Finance Ltd., Lloyd's Banking Group, Morgan Stanley, Royal Bank of Canada, Royal Bank of Scotland plc, UBS, Wells Fargo, Divvy Homes, Inc., and Pronto Housing. These players have adopted various strategies to increase their market penetration and strengthen their position in the housing finance industry.

Companies Mentioned

  • Bank of America Corporation
  • Charles Schwab & Co.
  • Citigroup, Inc.
  • Credit Suisse
  • Dewan Housing Finance Corporation Limited
  • Goldman Sachs
  • Hsbc Group
  • Jpmorgan Chase & Co.
  • Lic Housing Finance Limited
  • Lloyd's Banking Group
  • Morgan Stanley
  • Royal Bank of Canada
  • The Royal Bank of Scotland plc
  • Ubs
  • Wells Fargo

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...